Common questions about Мирапекс ПД (FAQ)
Q: Is Mirapex PD authorized only for Parkinson’s disease?
Official product information states that the extended-release formulation (Мирапекс ПД) is authorized for the treatment of Parkinson's disease. While the immediate-release version is authorized for moderate to severe restless legs syndrome (RLS) in some regions, the extended-release form is not considered suitable for RLS.
Q: What is the main difference between Mirapex PD and regular Mirapex?
The primary difference lies in the release mechanism and dosing frequency. Мирапекс ПД (extended-release) is designed to release the active ingredient slowly over 24 hours and the dosing frequency is described as once daily. The regular immediate-release tablet is typically taken multiple times a day. Official administration guidelines state the extended-release tablet must be swallowed whole and should not be divided or crushed.
Q: Are there long-term side effects described in studies?
Studies, including long-term open-label extensions lasting nearly two years, examined the safety profile of the medication. The evidence indicates that the reported adverse reactions were generally consistent with those expected for this class of medication. No new or unexpected long-term safety signals were identified compared to the immediate-release formulation.
Q: Is Mirapex PD used in elderly patients?
The medication is approved for use in adults, which includes the elderly population. However, official safety information notes that certain adverse reactions, such as confusion and hallucinations, may increase in frequency with age.
Q: How does Mirapex PD affect the ability to drive vehicles?
Regulatory documents contain specific warnings regarding driving and operating machinery. Due to the risk of somnolence (drowsiness) and sudden onset of sleep without warning, regulatory guidance advises against driving or engaging in potentially dangerous activities until the patient knows how the medication affects them.
Q: Does this drug affect mood or emotions?
The official safety profile includes potential effects on mood, cognition, and behavior. Documented reactions include confusion, hallucinations, and a decrease in libido. Impulse control disorders, such as pathological gambling or hypersexuality, are also listed as uncommon adverse reactions.
Q: Can the side effects of the drug disappear over time?
Official regulatory information suggests that certain transient side effects are more likely to occur early in the course of treatment. This includes issues like dizziness and orthostatic hypotension (a drop in blood pressure when standing up). For some of these initial symptoms, evidence indicates they may lessen over time.
Q: Can taking Mirapex PD affect the nature of dreams?
Yes, official safety information lists abnormal dreams as a possible adverse reaction. This is generally noted as a less common effect in the product's safety profile.
Q: How quickly do patients usually start to feel the effect of Mirapex PD, and when can a difference be noticed?
Clinical studies tracked objective symptom changes compared to a placebo. Evidence indicates that a statistically significant difference in symptom reduction was observed after approximately three weeks of dose titration, during the period of dose adjustment (titration).
Q: Is this a medicine that needs to be taken constantly?
As the medication is utilized for the symptomatic management of Parkinson's disease, which is a progressive and chronic condition, treatment is typically continuous. Official guidelines describe that medication use should cease via a gradual dose tapering process, as abrupt discontinuation is not recommended.
Q: Are any tests required before starting Mirapex PD?
Official regulatory documents indicate that an assessment of kidney function (renal clearance) is necessary before beginning treatment. This assessment is required because the dosage must be adjusted in patients who have renal impairment to prevent drug accumulation.
Q: What to do for nausea related to the drug (general information)?
Nausea is listed as a very common side effect. Official prescribing information notes that administering the extended-release tablet with food may help to reduce the occurrence of nausea, without affecting the overall absorption of the active ingredient.
Q: Why do some people say they feel 'better' on this drug?
Clinical studies report objective measures related to effectiveness, focusing on changes in functional outcomes. These studies showed a significant reduction in the severity of motor symptoms associated with Parkinson's disease, such as difficulties with daily living activities, compared to placebo.